Showing results (1-10 of 210) with videos related to
Sort By:
Pageof 21
Current Opinion in Molecular Therapeutics|August 7, 2008
Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapyChae-Ok YunMolecular and Cellular Endocrinology|January 15, 2019
Relaxin gene therapy: A promising new treatment option for various diseases with aberrant fibrosis or irregular angiogenesisJinWoo Hong, Chae-Ok YunCells|May 1, 2019
Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Various DiseasesJinWoo Hong, Chae-Ok YunBMB Reports|December 30, 2010
Current advances in adenovirus nanocomplexes: more specificity and less immunogenicityEunah Kang, Chae-Ok YunBMC Biomedical Engineering|September 9, 2020
Overcoming the limitations of locally administered oncolytic virotherapyJinWoo Hong, Chae-Ok YunCurrent Cancer Drug Targets|February 24, 2017
Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?JinWoo Hong, Chae-Ok YunJournal of Controlled Release : Official Journal of the Controlled Release Society|February 24, 2021
Overcoming the barriers to optimization of adenovirus delivery using biomaterials: Current status and future perspectiveDayananda Kasala, JinWoo Hong, Chae-Ok YunCells|November 7, 2019
Regulatory T Cells Induce Metastasis by Increasing Tgf-β and Enhancing the Epithelial–Mesenchymal TransitionEonju Oh, JinWoo Hong, Chae-Ok YunInternational Journal of Molecular Sciences|November 19, 2020
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical TrialsJune Kyu Hwang, JinWoo Hong, Chae-Ok YunOncotarget|October 3, 2015
A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growthA-Rum Yoon, Jinwoo Hong, Chae-Ok YunPageof 21